Based on the best available evidence, variants in BRCA1, BRCA2, BRIP1, RAD51C, RAD51D, and the mismatch repair genes confer ovarian cancer risks that warrant the consideration of risk-reducing surgery. Here, BRCA2 is linked to ovarian carcinoma.